tiprankstipranks
Trending News
More News >
Modern Dental Group Limited (HK:3600)
:3600
Advertisement

Modern Dental Group Limited (3600) AI Stock Analysis

Compare
3 Followers

Top Page

HK:3600

Modern Dental Group Limited

(Frankfurt:3600)

Rating:74Outperform
Price Target:
HK$4.50
▼(-16.82% Downside)
Modern Dental Group demonstrates a strong financial foundation and appealing valuation, offset by technical indicators that suggest a neutral market sentiment. The absence of recent cash flow data is a notable risk that needs addressing to ensure continued financial health.

Modern Dental Group Limited (3600) vs. iShares MSCI Hong Kong ETF (EWH)

Modern Dental Group Limited Business Overview & Revenue Model

Company DescriptionModern Dental Group Limited, an investment holding company, engages in production and distribution of dental prosthetic devices in Europe, Greater China, North America, Australia, and internationally. It operates through three segments: Fixed Prosthetic Devices, Removable Prosthetic Devices, and Others. The Fixed Prosthetic Devices segment offers restorative dental procedures, such as crowns, bridges, and implant. The Removable Prosthetic Devices segment produces full and partial dentures with and without metal frameworks. The Others segment offers orthodontic devices, sports guards, anti-snoring devices, raw materials, and dental equipment. This segment also provides services for educational events and seminars. The company sells its products to dentists, dental clinics, hospitals, distributors, and other customers under the Permadental & Semperdent, Schmidt, Apex Digital Dental, Elysee, Labocast, Modern Dental Laboratory, Yangzhijing, Southern Cross Dental, Andent, Modern Dental USA, Sundance Dental, Quantum Dental, TrioClear, and Digitek Dental brands. Modern Dental Group Limited was founded in 1986 and is based in Kowloon, Hong Kong.
How the Company Makes MoneyModern Dental Group Limited generates revenue primarily through the sale of dental prosthetic devices and related services. Its key revenue streams include the manufacturing and distribution of dental products, such as crowns, bridges, and dentures, to dental professionals and institutions. The company leverages a global network of distribution channels and strategic partnerships to expand its market reach and enhance its service offerings. Additionally, Modern Dental Group invests in research and development to innovate and improve its product line, thereby maintaining a competitive edge in the dental industry. Revenue growth is supported by the increasing demand for dental services and the company's ability to provide customized, high-quality dental solutions to its clients.

Modern Dental Group Limited Financial Statement Overview

Summary
Modern Dental Group shows strong financial performance with solid revenue growth, profitability, and a stable balance sheet. However, the absence of recent cash flow data is a concern, indicating potential risks in cash management.
Income Statement
85
Very Positive
Modern Dental Group has demonstrated a strong income statement performance with a consistent increase in total revenue over recent years. The company reported a gross profit margin of approximately 53.5% for the most recent period, and the net profit margin stands at around 12.1%. Both EBIT and EBITDA margins are solid at 15.9% and 19.8%, respectively. The revenue growth rate from 2023 to 2024 was about 6.06%, indicating a positive growth trajectory. Overall, the income statement reflects strong profitability and growth, though there is room for improvement in EBIT consistency.
Balance Sheet
78
Positive
The balance sheet of Modern Dental Group shows a stable financial position with a debt-to-equity ratio of approximately 0.34, indicating moderate leverage. The return on equity (ROE) for the latest period is about 15.0%, which is robust and demonstrates effective management of equity. The equity ratio is a strong 66.7%, highlighting a solid equity base relative to assets. While the company's leverage is under control, continuous monitoring is advised to maintain this stability.
Cash Flow
72
Positive
The cash flow analysis for Modern Dental Group reveals some challenges, particularly with the reporting of operating cash flow and free cash flow being zero for the most recent period. Historically, the company has shown positive free cash flow growth, and the operating cash flow to net income ratio was healthy in previous years. However, the lack of cash flow data for the latest period raises concerns about cash management, which needs addressing to ensure liquidity and operational efficiency.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue3.36B3.17B2.83B2.96B2.19B
Gross Profit1.80B1.70B1.38B1.55B1.09B
EBITDA719.12M696.64M464.09M627.01M295.21M
Net Income408.00M404.10M220.46M360.82M107.76M
Balance Sheet
Total Assets4.07B3.95B3.54B3.66B3.67B
Cash, Cash Equivalents and Short-Term Investments816.83M697.69M447.72M638.00M702.65M
Total Debt924.22M852.20M788.19M833.09M1.03B
Total Liabilities1.35B1.31B1.21B1.30B1.41B
Stockholders Equity2.72B2.63B2.32B2.35B2.25B
Cash Flow
Free Cash Flow367.69M416.04M53.36M369.27M303.87M
Operating Cash Flow521.19M575.76M238.72M510.72M376.32M
Investing Cash Flow-145.47M-154.96M-227.55M-140.83M-47.32M
Financing Cash Flow-227.70M-173.64M-184.09M-439.50M-32.95M

Modern Dental Group Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price5.41
Price Trends
50DMA
4.37
Positive
100DMA
4.19
Positive
200DMA
4.02
Positive
Market Momentum
MACD
0.29
Negative
RSI
73.72
Negative
STOCH
79.02
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3600, the sentiment is Positive. The current price of 5.41 is above the 20-day moving average (MA) of 4.60, above the 50-day MA of 4.37, and above the 200-day MA of 4.02, indicating a bullish trend. The MACD of 0.29 indicates Negative momentum. The RSI at 73.72 is Negative, neither overbought nor oversold. The STOCH value of 79.02 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:3600.

Modern Dental Group Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (46)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
€4.96B12.3015.04%3.18%6.05%1.32%
46
Neutral
C$209.14M-0.30-24.12%3.18%19.38%-2.35%
€1.13B14.3318.36%
€227.87M11.203.72%
75
Outperform
HK$20.13B34.8324.57%0.68%13.58%24.59%
73
Outperform
HK$6.03B27.0911.24%0.88%11.23%20.39%
64
Neutral
HK$11.93B240.891.33%0.66%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:3600
Modern Dental Group Limited
5.41
1.86
52.57%
DE:50J
Kangji Medical Holdings Limited
0.92
0.31
50.82%
DE:PWE
PW Medtech Group Ltd.
0.14
0.04
40.00%
HK:1501
Shanghai Kindly Medical Instruments Co., Ltd. Class H
34.50
7.50
27.78%
HK:2276
Shanghai Conant Optical Co. Ltd. Class H
44.84
32.28
257.01%
HK:6699
Angelalign Technology Inc.
65.75
12.61
23.73%

Modern Dental Group Limited Corporate Events

Modern Dental Group Schedules Board Meeting for Interim Results
Aug 15, 2025

Modern Dental Group Limited has announced a board meeting scheduled for August 28, 2025, to review and approve the unaudited interim results for the first half of 2025. The meeting will also consider the declaration or payment of dividends, which could impact the company’s financial strategy and shareholder returns.

Modern Dental Group Projects Strong Profit Growth for 1H 2025
Aug 14, 2025

Modern Dental Group Limited announced a positive profit alert for the first half of 2025, with expected revenue growth between 4.3% and 8.7%, and a net profit increase between 30.1% and 37.6% compared to the same period in 2024. The growth is attributed to organic expansion, improved operational efficiency through digital solutions, favorable currency movements, and the strategic acquisition of Hexa Ceram, enhancing the company’s market position and financial performance.

Modern Dental Group Sees Revenue Growth Amid Strategic Expansion
May 29, 2025

Modern Dental Group Limited reported a 5.3% increase in revenue for the first quarter of 2025, driven by strategic acquisitions and digital transformation efforts. Despite challenges in certain markets, the company has successfully leveraged global digitalization trends to enhance its competitiveness and market share, particularly through the acquisition of Hexa Ceram and a focus on mid- to high-value customers.

Modern Dental Group’s AGM Approves Key Resolutions
May 29, 2025

Modern Dental Group Limited held its annual general meeting on May 29, 2025, where all proposed resolutions were approved by shareholders. Key resolutions included the approval of the audited financial statements for 2024, the declaration of a final dividend, the re-election of directors, and the re-appointment of Ernst & Young as auditors. The meeting also granted the board general mandates to buy back shares and issue additional shares, reflecting shareholder confidence in the company’s strategic direction.

Modern Dental Group Strengthens Governance with New Appointment
May 29, 2025

Modern Dental Group Limited has announced the appointment of Ms. Chan Yik Yu as a member of its nomination committee, effective from May 29, 2025. This strategic appointment is expected to enhance the company’s governance structure, potentially impacting its operational efficiency and stakeholder confidence.

Modern Dental Group Limited Announces Board Composition
May 29, 2025

Modern Dental Group Limited has announced the composition of its board of directors and the roles and functions of each member. This announcement highlights the company’s commitment to strong corporate governance and strategic leadership, which may impact its operational efficiency and market positioning positively.

Modern Dental Group Updates Nomination Committee Terms
May 29, 2025

Modern Dental Group Limited has updated the terms of reference for its Nomination Committee, initially adopted in 2015 and previously updated in 2018. The committee is tasked with ensuring a fair and transparent process for board appointments, identifying suitable candidates, and making recommendations to the board and shareholders. This update underscores the company’s commitment to robust governance practices, potentially enhancing its industry positioning and stakeholder trust.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 03, 2025